Cover Image

Management of acute and delayed chemotherapy-induced nausea and vomiting: role of netupitant–palonosetron combination

Piotr K JanickiDepartment of Anesthesiology and Perioperative Medicine, Milton S Hershey Medical Center, Pennsylvania State University College of Medicine, Hershey, PA, USAPurpose: The purpose of this review is to summarize and discuss the recently published data (both original studies and reviews)...

Full description

Saved in:

Bibliographic Details
Main Author:	Janicki PK (Author)
Format:	Book
Published:	Dove Medical Press, 2016-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Management of chemotherapy-induced nausea and vomiting by risk profile: role of netupitant/palonosetron
by: Lorusso V
Published: (2016)

Netupitant/palonosetron (NEPA; Akynzeo®) combination in prevention of the nausea and vomiting in patients with breast cancer receiving anthracyclinbased chemotherapy
by: A. G. Kedrova, et al.
Published: (2023)

Update on the management of chemotherapy-induced nausea and vomiting – focus on palonosetron
by: Zhou M, et al.
Published: (2015)

NEPA, a new fixed combination of netupitant and palonosetron, is a cost-effective intervention for the prevention of chemotherapy-induced nausea and vomiting in the UK
by: Helene Cawston, et al.
Published: (2017)

Profile of netupitant/palonosetron (NEPA) fixed dose combination and its potential in the treatment of chemotherapy-induced nausea and vomiting (CINV)
by: Navari RM
Published: (2014)

Management of postoperative nausea and vomiting: focus on palonosetron
by: Neil A Muchatuta, et al.
Published: (2008)

A Phase II single-arm trial of palonosetron for the prevention of acute and delayed chemotherapy-induced nausea and vomiting in malignant glioma patients receiving multidose irinotecan in combination with bevacizumab
by: Affronti ML, et al.
Published: (2016)

Antiemetic efficacy and safety of granisetron or palonosetron alone and in combination with a corticosteroid for ABVD therapy-induced nausea and vomiting
by: Mayako Uchida, et al.
Published: (2018)

Adding aprepitant to palonosetron does not decrease carboplatin-induced nausea and vomiting in patients with gynecologic cancer
by: Yuko Watanabe, et al.
Published: (2021)

Clinician preference and comparison of the efficacy of ondansetron, granisetron, and palonosetron in preventing chemotherapy-induced nausea and vomiting among children receiving moderate or highly emetogenic chemotherapy
by: Rohan Bansal, et al.
Published: (2023)

Differential clinical pharmacology of rolapitant in delayed chemotherapy-induced nausea and vomiting (CINV)
by: Rashad N, et al.
Published: (2017)

Profile of Antiemetic Activity of Netupitant Alone or in Combination with Palonosetron and Dexamethasone in Ferrets and Suncus murinus (house musk shrew)
by: John A Rudd, et al.
Published: (2016)

Aromatherapy Applications in The Management of The Chemotherapy-Induced Nausea and Vomiting
by: Nuriye Efe Erturk, et al.
Published: (2021)

Efficacy of the combination use of aprepitant and palonosetron for improving nausea in various moderately emetogenic chemotherapy regimens
by: Naohisa Yoshida, et al.
Published: (2019)

Concomitant palonosetron ameliorates cisplatin-induced nephrotoxicity, nausea, and vomiting: a retrospective cohort study and pharmacovigilance analysis
by: Miho Takemura, et al.
Published: (2022)

Prospective randomized trial with Palonosetron verses ondensetron for postoperative nausea and vomitting in general surgical population
by: Meenal Agarwal, et al.
Published: (2016)

Comparison of ondansetron, tropisetron, and palonosetron for the prevention of postoperative nausea and vomiting after middle ear surgery
by: Ahmet Aydin, MD, et al.
Published: (2019)

Economic analysis of palonosetron versus granisetron in the standard triplet regimen for preventing chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy in Japan (TRIPLE phase III trial)
by: Hisanori Shimizu, et al.
Published: (2018)

A comparative study between palonosetron and granisetron to prevent postoperative nausea and vomiting after laparoscopic cholecystectomy
by: Dhurjoti Prosad Bhattacharjee, et al.
Published: (2010)

Recent advances in pharmacotherapy of chemotherapy-induced nausea and vomiting
by: Prasan R Bhandari
Published: (2012)

Recent advances in pharmacotherapy of chemotherapy-induced nausea and vomiting.
by: Prasan R Bhandari
Published: (2012)

Benefits of ginger in the control of chemotherapy-induced nausea and vomiting
by: Dayane Oliveira Borges, et al.

Incidence and management of chemotherapy-induced nausea and vomiting in women with breast cancer
by: Thais de Oliveira Gozzo, et al.

A randomized study to compare palonosetron with ondansetron for prevention of postoperative nausea and vomiting following middle ear surgeries
by: Shubhangi Sharma, et al.
Published: (2019)

A review of nabilone in the treatment of chemotherapy-induced nausea and vomiting
by: Mark A Ware, et al.
Published: (2008)

Risk factors associated with antineoplastic chemotherapy-induced nausea and vomiting
by: Giovana Paula Rezende Simino, et al.
Published: (2020)

GIP receptor agonism blocks chemotherapy-induced nausea and vomiting
by: Tito Borner, et al.
Published: (2023)

Effect of Auricular Acupressure on Acute Nausea and Vomiting Induced by Chemotherapy among Breast Cancer Patients
by: Mohammad Eghbali, et al.
Published: (2015)

Effect of Auricular Acupressure on Acute Nausea and Vomiting Induced by Chemotherapy among Breast Cancer Patients
by: Mohammad Eghbali, et al.
Published: (2015)

Research trends on chemotherapy induced nausea and vomiting: a bibliometric analysis
by: Chunhui Ning, et al.
Published: (2024)

Olanzapine for chemotherapy-induced nausea and vomiting: systematic review and meta-analysis
by: Chelkeba L, et al.
Published: (2017)

Non Pharmacological Interventions for Chemotherapy Induced Nauseas and Vomits: integrative review
by: Dacirene Ribeiro França Silva, et al.
Published: (2009)

Effect of ondansetron alone and in combination with domperidone in the prevention of chemotherapy-induced nausea and vomiting in breast cancer patients
by: Kaberi Das Gupta, A.K.M. Mosharrof Hossain, Saad Uddin Jaigirdar, Borhan Uddin, Tridiv Choudhury and Dipti Rani Saha
Published: (2007)

Effects of ondansetron alone and in combination with domperidone in the prevention of chemotherapy-induced nausea and vomiting in breast cancer patients
by: Kaberi Das Gupta, et al.
Published: (2007)

Adherence to guidelines for management of chemotherapy-induced nausea and vomiting in a tertiary public hospital
by: Gustavo M. LÁZARO, et al.
Published: (2020)

Doxylamine succinate–pyridoxine hydrochloride (Diclegis) for the management of nausea and vomiting in pregnancy: an overview
by: Nuangchamnong N, et al.
Published: (2014)

An assessment of chemotherapy-induced nausea and vomiting direct costs in three EU countries
by: Marco Turini, et al.
Published: (2015)

Assessment of chemotherapy-induced nausea and vomiting in pediatrics: Adequacy of control and adherence to guidelines
by: Sameh Awwad, et al.
Published: (2023)

The effect of reflexology on chemotherapy-induced nausea, vomiting, and fatigue in breast cancer patients
by: Afitap Özdelikara, et al.
Published: (2017)

Higher dose of palonosetron versus lower dose of palonosetron plus droperidol to prevent postoperative nausea and vomiting after eye enucleation and orbital hydroxyapatite implant surgery: a randomized, double-blind trial
by: Hu X, et al.
Published: (2017)